Deakin University
Browse

Cost-effectiveness of interventions for anxiety and depressive disorders

Version 2 2024-06-03, 12:48
Version 1 2018-04-16, 12:27
chapter
posted on 2024-06-03, 12:48 authored by Cathy MihalopoulosCathy Mihalopoulos, ML Chatterton
© Springer International Publishing AG 2017. Depression and anxiety disorders are highly prevalent diagnoses associated with significant morbidity and economic burden to healthcare systems and society. It is important to consider the costs and outcomes of the various pharmacologic and psychologic therapies available for the treatment and prevention of these diagnoses in order to provide services in the most efficient way. This chapter reviews the numerous economic evaluations previously undertaken to evaluate medications and the psychological (both in-person and Internet-based) and combination therapies used as treatments for diagnosed depression and anxiety. It also reviews the growing literature on interventions for the prevention of these conditions. A discussion of methodologic concerns is included to provide guidance for interpreting the existing evidence and as a basis for the design of future evaluations.

History

Pagination

283-298

ISBN-13

9783319552668

Publication classification

BN Other book chapter, or book chapter not attributed to Deakin

Publisher

Springer

Place of publication

Cham, Switzerland

Title of book

Mental Health Economics: The Costs and Benefits of Psychiatric Care

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC